About Lairus Pharma Private Limited
Data last updated:
Lairus Pharma Private Limited is a private limited company based in Nashik, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 22 July 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2022PTC387383. Its GSTIN is 27AAKCC4878K1ZZ (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anant Kanhoba Ghumare and Mahesh Jadhav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 104/1 Ambad MIDC, Nashik, Maharashtra, India – 422010.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.82 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹9,060 (net margin 1.9%) and EBITDA of ₹2.65 Lakh (EBITDA margin 55.1%).
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lairuspharma.com.
Company details
Contact details
Lairus Pharma Private Limited's registered office is in Nashik, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Social Media
- Registered AddressD – 104/1 Ambad MIDC, Nashik, Maharashtra, India – 422010
- IndustryPharma, API Manufacturers
To see the full contact details of Lairus Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lairus Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Lairus Pharma Private Limited, buy the company report.
Financials of Lairus Pharma Private Limited
FY 2025 filings availableLairus Pharma Private Limited reported revenue of ₹4.82 Lakh (up 22247% YoY) for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹2.65 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹9,060 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 55.1% | |
| Net Profit Margin | 1.9% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Lairus Pharma Private Limited, buy the company report.
Board of directors of Lairus Pharma Private Limited
Lairus Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anant Kanhoba Ghumare Also directs: Imperia Herbals LLP | Director | 22 Jul 2022 | 4 Years 3 Months | Current |
| Mahesh Jadhav | Director | 05 Oct 2022 | 4 Years 0 Months | Current |
Auditor
Lairus Pharma Private Limited is audited by N S M & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N S M & CO | FY 2023 | 143444W |
Shareholding
The shareholding of Lairus Pharma Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Lairus Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lairus Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lairus Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Lairus Pharma Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
GST
Lairus Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAKCC4878K1ZZ | Maharashtra | Active | 07 Nov 2022 |
To see the full GST registrations and return filing status of Lairus Pharma Private Limited, buy the company report.
Recent activity
Lairus Pharma Private Limited has 5 board changes on record since 2022: 2 appointments and 3 cessations. The latest: Kunal Madhav Jagtap ceased to be Director on 15 Jul 2023.
Frequently asked questions
Lairus Pharma is an active private limited company based in Nashik, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 22 July 2022 (4+ years old) and is registered under CIN U24290MH2022PTC387383.
Lairus Pharma has 2 current directors:
- Anant Kanhoba Ghumare - Director
- Mahesh Jadhav - Director
The latest financial statements of Lairus Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Lairus Pharma is 27AAKCC4878K1ZZ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Lairus Pharma is U24290MH2022PTC387383. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lairus Pharma was incorporated on 22 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
Kunal Madhav Jagtap ceased to be Director on 15 Jul 2023. Amol Ashok Gavande ceased to be Director on 14 Jul 2023. Mahesh Jadhav ceased to be Director on 14 Jul 2023. Lairus Pharma has 5 board changes on record in total.
Lairus Pharma can be reached through the website lairuspharma.com. Its registered office is in Nashik, Maharashtra, India.
The registered office of Lairus Pharma is at D – 1041 Ambad MIDC, Nashik, Maharashtra, India – 422010.
Lairus Pharma operates in the pharma industry, in the api manufacturers segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
